End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 USD | +4.05% | +4,826.94% | -.--% |
05-13 | SurgePays Q1 Earnings, Revenue Fall | MT |
05-13 | Transcript : SurgePays, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 13.98 | 24.33 | 82.2 | 92.51 | 81.28 | - |
Enterprise Value (EV) 1 | 13.98 | 24.33 | 82.2 | 92.51 | 36.35 | 25.99 |
P/E ratio | -58.8 x | -0.65 x | -131 x | 4.67 x | 141 x | 5.98 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | 0.48 x | 0.68 x | 0.67 x | 0.84 x | 0.68 x |
EV / Revenue | - | 0.48 x | 0.68 x | 0.67 x | 0.38 x | 0.22 x |
EV / EBITDA | - | -6.24 x | 36.3 x | 4.14 x | 2.95 x | 1.05 x |
EV / FCF | - | - | - | - | 4.9 x | 1.67 x |
FCF Yield | - | - | - | - | 20.4% | 59.7% |
Price to Book | - | - | 18.6 x | 3.29 x | 1.62 x | 1.17 x |
Nbr of stocks (in thousands) | 2,379 | 12,047 | 12,531 | 14,343 | 19,283 | - |
Reference price 2 | 5.875 | 2.020 | 6.560 | 6.450 | 4.215 | 4.215 |
Announcement Date | 02/04/21 | 24/03/22 | 30/03/23 | 12/03/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | - | 51.06 | 121.5 | 137.1 | 96.66 | 119.8 |
EBITDA 1 | - | -3.898 | 2.265 | 22.32 | 12.31 | 24.8 |
EBIT 1 | - | -5.993 | 0.6338 | 18.87 | 1.469 | 17.04 |
Operating Margin | - | -11.74% | 0.52% | 13.76% | 1.52% | 14.22% |
Earnings before Tax (EBT) 1 | - | -13.53 | -0.5532 | 18.38 | 1.053 | 17.81 |
Net income 1 | -10.72 | -13.53 | -0.6808 | 20.62 | 0.642 | 14.26 |
Net margin | - | -26.5% | -0.56% | 15.03% | 0.66% | 11.9% |
EPS 2 | -0.1000 | -3.090 | -0.0500 | 1.380 | 0.0300 | 0.7050 |
Free Cash Flow 1 | - | - | - | - | 7.415 | 15.52 |
FCF margin | - | - | - | - | 7.67% | 12.95% |
FCF Conversion (EBITDA) | - | - | - | - | 60.22% | 62.56% |
FCF Conversion (Net income) | - | - | - | - | 1,154.98% | 108.82% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 02/04/21 | 24/03/22 | 30/03/23 | 12/03/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 14.16 | 21.14 | 28.01 | 36.17 | 36.23 | 34.78 | 35.89 | 34.16 | 32.32 | 31.43 | 23.35 | 24.17 | 24.83 | 28.23 | 29.15 |
EBITDA 1 | -0.5836 | -0.8791 | -0.656 | -0.7663 | 4.119 | 5.015 | 6.393 | 7.325 | 3.415 | 2.082 | -0.497 | 1.253 | 2.203 | 4.9 | 4.8 |
EBIT 1 | -2.099 | -1.05 | -0.8475 | -0.9649 | 3.545 | 4.705 | 6.202 | 7.092 | 0.8662 | 1.752 | -1.319 | 0.8 | 1.77 | 3.34 | 3.39 |
Operating Margin | -14.83% | -4.97% | -3.03% | -2.67% | 9.79% | 13.53% | 17.28% | 20.76% | 2.68% | 5.57% | -5.65% | 3.31% | 7.13% | 11.83% | 11.63% |
Earnings before Tax (EBT) 1 | -6.844 | -1.245 | -0.8919 | -1.709 | 3.341 | 4.546 | 6.057 | 7.013 | 0.7638 | 1.635 | -1.295 | 1.1 | 1.875 | 3.5 | 3.556 |
Net income 1 | -6.844 | -1.212 | -0.973 | -1.493 | 3.021 | 4.546 | 5.966 | 7.084 | 3.021 | 1.225 | -1.128 | 0.8 | 1.575 | 2.77 | 2.844 |
Net margin | -48.35% | -5.73% | -3.47% | -4.13% | 8.34% | 13.07% | 16.62% | 20.74% | 9.35% | 3.9% | -4.83% | 3.31% | 6.34% | 9.81% | 9.76% |
EPS 2 | -0.8800 | -0.1000 | -0.0700 | -0.1200 | 0.2500 | 0.3100 | 0.4000 | 0.4900 | 0.1900 | 0.0700 | -0.0600 | 0.0400 | 0.0800 | 0.1400 | 0.1400 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 24/03/22 | 16/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 12/03/24 | 13/05/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | - | - | - | - | 44.9 | 55.3 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | - | 7.42 | 15.5 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | 0.3500 | 1.960 | 2.600 | 3.610 |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | 0.05 | 0.01 | - | 2.9 | 2.9 |
Capex / Sales | - | 0.1% | 0.01% | - | 3% | 2.42% |
Announcement Date | 02/04/21 | 24/03/22 | 30/03/23 | 12/03/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.74% | 208B | |
+6.26% | 169B | |
+1.15% | 118B | |
-10.91% | 82.11B | |
+19.25% | 71.25B | |
+4.19% | 61.11B | |
-5.07% | 50.52B | |
-29.76% | 39.32B | |
-18.02% | 38.12B |
- Stock Market
- Equities
- SURG Stock
- SURG Stock
- Financials SURGEPAYS